FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955074537> ?p ?o ?g. }

• W2955074537 endingPage "1025" @default.
• W2955074537 startingPage "1017" @default.
• W2955074537 abstract "Despite decades of use, the actual amounts of topical corticosteroids (TCS) and emollients used in moderate-to-severe atopic dermatitis (AD) under real-world conditions are unknown. Thus, it remains unclear whether inadequate use is widespread.To quantify the use of TCS and emollients in moderate-to-severe AD.Double-blinded drug prescribing was recorded prospectively at the point of drug dispensing within a catchment area of approximately 450 000 people over a 31-year period in a population-based cohort marked by failure of disease control in primary care (n = 844). For each patient, prescribing was recorded over a 12-month period in order to minimize fluctuations.This approach resulted in a near-complete dataset, which was essentially free of reporting bias and recording bias. Atopic comorbidities matched expected frequencies. Median use of TCS was statistically significantly higher in juvenile patients (age < 16 years) compared with adult patients (49·2 vs. 38·1 g per month), in male vs. female patients (46·8 vs. 29·7 g per month) and in patients receiving concurrent asthma treatment (40·4 vs. 26·7 g per month). TCS use was strongly associated with antidepressant treatment. Emollient use was unexpectedly low with a median of 9·6 g per day (range 1·4-30·1). Results were replicated in an independent validation cohort.Deficient use of emollients may be a factor contributing to AD severity. Our analysis showed that the use of TCS does not exceed current guidelines. Accurate quantification of topical treatments provides a widely accessible strategy to measure the real-world impact of novel AD treatments. What's already known about this topic? Both emollient and topical corticosteroid (TCS) use have been a mainstay of atopic dermatitis (AD) treatment for over 60 years. The actual quantities used by patients under real-world conditions are unknown. What does this study add? The real-world use of emollients is fourfold lower than the amount recommended in current guidelines. Underuse of emollients may be a significant factor in disease exacerbation. The use of TCS is significantly higher in male patients and is higher in patients with AD who also have asthma. The use of TCS is strongly associated with concurrent antidepressant treatment." @default.
• W2955074537 created "2019-07-12" @default.
• W2955074537 creator A5014733082 @default.
• W2955074537 creator A5015600591 @default.
• W2955074537 creator A5051235443 @default.
• W2955074537 creator A5053878238 @default.
• W2955074537 creator A5081030146 @default.
• W2955074537 creator A5082991728 @default.
• W2955074537 date "2019-09-15" @default.
• W2955074537 modified "2023-09-30" @default.
• W2955074537 title "Quantitative analysis of topical treatments in atopic dermatitis: unexpectedly low use of emollients and strong correlation of topical corticosteroid use both with depression and concurrent asthma" @default.
• W2955074537 cites W1580124467 @default.
• W2955074537 cites W1894106475 @default.
• W2955074537 cites W2264770719 @default.
• W2955074537 cites W2341603405 @default.
• W2955074537 cites W2408885425 @default.
• W2955074537 cites W2467821733 @default.
• W2955074537 cites W2520198258 @default.
• W2955074537 cites W2613543041 @default.
• W2955074537 cites W2615987905 @default.
• W2955074537 cites W2622757114 @default.
• W2955074537 cites W2790635214 @default.
• W2955074537 cites W2807789068 @default.
• W2955074537 cites W2887210237 @default.
• W2955074537 cites W2895948449 @default.
• W2955074537 cites W2899071879 @default.
• W2955074537 cites W2900213577 @default.
• W2955074537 cites W2921068606 @default.
• W2955074537 cites W4235711314 @default.
• W2955074537 doi "https://doi.org/10.1111/bjd.18265" @default.
• W2955074537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31257575" @default.
• W2955074537 hasPublicationYear "2019" @default.
• W2955074537 type Work @default.
• W2955074537 sameAs 2955074537 @default.
• W2955074537 citedByCount "9" @default.
• W2955074537 countsByYear W29550745372019 @default.
• W2955074537 countsByYear W29550745372020 @default.
• W2955074537 countsByYear W29550745372021 @default.
• W2955074537 countsByYear W29550745372022 @default.
• W2955074537 countsByYear W29550745372023 @default.
• W2955074537 crossrefType "journal-article" @default.
• W2955074537 hasAuthorship W2955074537A5014733082 @default.
• W2955074537 hasAuthorship W2955074537A5015600591 @default.
• W2955074537 hasAuthorship W2955074537A5051235443 @default.
• W2955074537 hasAuthorship W2955074537A5053878238 @default.
• W2955074537 hasAuthorship W2955074537A5081030146 @default.
• W2955074537 hasAuthorship W2955074537A5082991728 @default.
• W2955074537 hasBestOaLocation W29550745372 @default.
• W2955074537 hasConcept C126322002 @default.
• W2955074537 hasConcept C139719470 @default.
• W2955074537 hasConcept C141071460 @default.
• W2955074537 hasConcept C16005928 @default.
• W2955074537 hasConcept C162324750 @default.
• W2955074537 hasConcept C168563851 @default.
• W2955074537 hasConcept C187212893 @default.
• W2955074537 hasConcept C203092338 @default.
• W2955074537 hasConcept C2776042228 @default.
• W2955074537 hasConcept C2776804153 @default.
• W2955074537 hasConcept C2776867660 @default.
• W2955074537 hasConcept C2777520566 @default.
• W2955074537 hasConcept C2778329239 @default.
• W2955074537 hasConcept C2908647359 @default.
• W2955074537 hasConcept C71924100 @default.
• W2955074537 hasConcept C72563966 @default.
• W2955074537 hasConcept C99454951 @default.
• W2955074537 hasConceptScore W2955074537C126322002 @default.
• W2955074537 hasConceptScore W2955074537C139719470 @default.
• W2955074537 hasConceptScore W2955074537C141071460 @default.
• W2955074537 hasConceptScore W2955074537C16005928 @default.
• W2955074537 hasConceptScore W2955074537C162324750 @default.
• W2955074537 hasConceptScore W2955074537C168563851 @default.
• W2955074537 hasConceptScore W2955074537C187212893 @default.
• W2955074537 hasConceptScore W2955074537C203092338 @default.
• W2955074537 hasConceptScore W2955074537C2776042228 @default.
• W2955074537 hasConceptScore W2955074537C2776804153 @default.
• W2955074537 hasConceptScore W2955074537C2776867660 @default.
• W2955074537 hasConceptScore W2955074537C2777520566 @default.
• W2955074537 hasConceptScore W2955074537C2778329239 @default.
• W2955074537 hasConceptScore W2955074537C2908647359 @default.
• W2955074537 hasConceptScore W2955074537C71924100 @default.
• W2955074537 hasConceptScore W2955074537C72563966 @default.
• W2955074537 hasConceptScore W2955074537C99454951 @default.
• W2955074537 hasIssue "4" @default.
• W2955074537 hasLocation W29550745371 @default.
• W2955074537 hasLocation W29550745372 @default.
• W2955074537 hasLocation W29550745373 @default.
• W2955074537 hasLocation W29550745374 @default.
• W2955074537 hasOpenAccess W2955074537 @default.
• W2955074537 hasPrimaryLocation W29550745371 @default.
• W2955074537 hasRelatedWork W1908814627 @default.
• W2955074537 hasRelatedWork W2000906724 @default.
• W2955074537 hasRelatedWork W2002068458 @default.
• W2955074537 hasRelatedWork W2410563140 @default.
• W2955074537 hasRelatedWork W2473788747 @default.
• W2955074537 hasRelatedWork W2604148998 @default.
• W2955074537 hasRelatedWork W2769540774 @default.
• W2955074537 hasRelatedWork W2769649330 @default.
• W2955074537 hasRelatedWork W3154871868 @default.

• next